August 4, 2020 Clinical Research/Diagn. M&A, Partnerships Mass Spectrometry

Fluidigm and De Novo Software to Offer Mass Cytometry Customers a Streamlined Solution for Data Analysis

License for De Novo Software’s FCS Express 7 Flow to be Provided to Customers Purchasing Fluidigm Helios and Hyperion Imaging Systems SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a distribution agreement with De Novo Software™... Read more

August 3, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and Kantaro Biosciences to Launch a Quantitative Research Use Only COVID-19 Serology Test

MINNEAPOLIS and NEW YORK, Aug. 3, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team... Read more

August 3, 2020 Clinical Research/Diagn. Lab Top-10

OIE Approves Registration of VetMAX African Swine Fever Virus Detection Kit in Diagnostics Manual

OIE Approves Registration of VetMAX African Swine Fever Virus Detection Kit in Diagnostics Manual LISSIEU, France (June 30, 2020) — The World Organization for Animal Health (OIE) recently approved the registration of the Applied Biosystems VetMAX African Swine Fever Virus Detection Kit from Thermo Fisher Scientific in the OIE manual of diagnostic testing. It is... Read more

July 29, 2020 Acad, Gov/Utilities Clinical Research/Diagn. PAI Top-10 Product Launch

FDA approves Roche’s new VENTANA HER2 Dual ISH test as companion diagnostic to identify breast cancer patients eligible for targeted therapy

Nearly 2.1 million new cases of breast cancer are diagnosed worldwide each year, and more than 620,000 people will die from the disease.1 About 15 to 20 percent of women diagnosed with breast cancer are HER2 positive.2 VENTANA HER2 Dual ISH DNA Probe Cocktail assay3 aids in identifying HER2-positive breast cancer patients eligible for the... Read more

July 29, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Microscopy

Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia

COVACTA trial did not meet its primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia, or the key secondary endpoint of reduced patient mortality The study is the first global, randomised, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting Roche remains committed to continuing the Actemra/RoActemra clinical trial programme in... Read more

July 28, 2020 Clinical Research/Diagn. Informatics & Software Product Launch

Zymo Research Releases Free Software to Streamline COVID-19 Test Reporting

CALIFORNIA LABORATORIES CAN NOW INSTANTLY TRANSMIT COVID-19 DATA TO THE CALREDIE SYSTEM IRVINE, Calif., (July 28, 2020) — Zymo Research recently has released a free open-source software program that allows California laboratories to rapidly report COVID-19 test data to the California Reportable Disease Information Exchange (CalREDIE). According to the California Department of Public Health (CDPH) website,... Read more

July 22, 2020 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 Product Launch

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

Informatics Tools Help Scientists Access, Aggregate and Analyze Drug Compound and Clinical Trial Data WALTHAM, Mass. — July 22, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access Perkin Elmer COVID-19 Data Dashboards to help the global scientific community accelerate the... Read more

July 21, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Bio-Techne Announces Launch of Exocovid-19 Test for Detection of SARS-CoV-2 in Patient Samples

MINNEAPOLIS, July 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now offers the ExoCovid-19 test for detection of the virus in patient samples. The ExoCovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory. Exosome Diagnostics, the... Read more

July 20, 2020 Clinical Research/Diagn. Lab Top-10

Thermo Fisher Scientific's Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines

Thermo Fisher Scientific’s Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines Leading pharma services network brings unmatched scalability, flexibility and expertise to support the global response WALTHAM, Mass., July 20, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, continues to expand global... Read more

July 20, 2020 Clinical Research/Diagn. Lab Top-10

Thermo Fisher Scientific's Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines

Leading pharma services network brings unmatched scalability, flexibility and expertise to support the global response WALTHAM, Mass., July 20, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as... Read more